The Fort Worth Press - Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore

USD -
AED 3.672501
AFN 65.000137
ALL 81.297901
AMD 362.796361
ANG 1.789785
AOA 917.999705
ARS 1545.680346
AUD 1.453224
AWG 1.8
AZN 1.698478
BAM 1.751128
BBD 2.022649
BDT 125.223838
BGN 1.747831
BHD 0.378911
BIF 3004.498959
BMD 1
BND 1.283972
BOB 11.911754
BRL 5.582901
BSD 1.004405
BTN 94.392415
BWP 13.779334
BYN 3.007212
BYR 19600
BZD 2.019984
CAD 1.419505
CDF 2315.000078
CHF 0.825594
CLF 0.025004
CLP 984.097417
CNY 6.67035
CNH 6.67347
COP 3307.76
CRC 454.299234
CUC 1
CUP 24.105328
CVE 98.725915
CZK 21.803604
DJF 178.828163
DKK 6.69303
DOP 60.919432
DZD 136.502003
EGP 53.316906
ERN 15
ETB 161.150546
EUR 0.89538
FJD 2.25845
FKP 0.745155
GBP 0.748965
GEL 2.60138
GGP 0.745155
GHS 11.761335
GIP 0.745155
GMD 73.999827
GNF 8897.961742
GTQ 7.674952
GYD 210.461285
HKD 7.845505
HNL 26.999889
HRK 6.76901
HTG 131.649514
HUF 326.181497
IDR 18137
ILS 3.18295
IMP 0.745155
INR 93.70785
IQD 1522.620849
IRR 1906074.999586
ISK 122.502706
JEP 0.745155
JMD 159.406925
JOD 0.708988
JPY 158.807499
KES 129.930342
KGS 87.449802
KHR 4096.250699
KMF 441.999677
KPW 899.999961
KRW 1334.780493
KWD 0.31105
KYD 0.836967
KZT 448.414795
LAK 22606.912791
LBP 89940.147639
LKR 333.792943
LRD 170.741971
LSL 16.465622
LTL 2.95274
LVL 0.60489
LYD 6.438471
MAD 9.797561
MDL 18.047927
MGA 4589.999876
MKD 55.115995
MMK 2099.696522
MNT 3601.450067
MOP 8.115302
MRU 40.517153
MUR 46.919747
MVR 15.385115
MWK 1741.621825
MXN 18.60104
MYR 4.072966
MZN 63.89885
NAD 16.46599
NGN 1346.029846
NIO 36.750073
NOK 9.497205
NPR 151.027187
NZD 1.78162
OMR 0.384497
PAB 1.004405
PEN 3.422926
PGK 4.49825
PHP 63.147502
PKR 277.777828
PLN 3.93585
PYG 6199.364397
QAR 3.661271
RON 4.785007
RSD 105.338002
RUB 83.200043
RWF 1486.001307
SAR 3.757016
SBD 8.090747
SCR 13.985569
SDG 601.49623
SEK 9.8658
SGD 1.28116
SHP 0.749316
SLE 22.901353
SLL 20969.504398
SOS 574.004602
SRD 37.545985
STD 20697.981008
STN 21.935911
SVC 8.78869
SYP 13001.999685
SZL 16.470883
THB 33.600993
TJS 9.230273
TMT 3.5
TND 3.000294
TOP 2.40776
TRY 50.226399
TTD 6.811772
TWD 32.854994
TZS 2642.502955
UAH 45.682386
UGX 4098.023064
UYU 40.639633
UZS 12026.931445
VES 900.490505
VND 25627
VUV 120.001108
WST 2.780103
XAF 587.330878
XAG 0.019058
XAU 0.000247016961
XCD 2.70255
XCG 1.810116
XDR 0.707052
XOF 587.330878
XPF 107.249716
YER 236.502208
ZAR 16.50711
ZMK 9001.196363
ZMW 20.461036
ZWL 321.999592
SSP 5745.814556
MXV 2.090552
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore

Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore

LAFAYETTE, LA / ACCESS Newswire / September 24, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that Michael Moore, President of Viemed, has adopted an automatic securities disposition plan (the "ASDP") relating to common shares of the Company.

Text size:

Under applicable securities laws, insiders are subject to limits on their ability to sell shares. ASDPs permit trades to be made in accordance with pre-arranged instructions given when the insider is not in possession of any material undisclosed information, on an automatic basis, regardless of any subsequent material non-public information the insider receives. Once an ASDP is established, the insider is not permitted to exercise any further discretion or influence over how dispositions will occur under the ASDP.

The ASDP was established in accordance with applicable United States and Canadian securities laws and Viemed's internal policies. The ASDP consists of a pre-arranged trading plan administered by Morgan Stanley Smith Barney LLC ("Morgan Stanley") pursuant to Rule 10b5-1 under the U.S. Securities Exchange Act of 1934 with respect to common shares of Viemed held by Moore Faster LLC, an entity controlled by Mr. Moore. Mr. Moore has provided pre-arranged instructions in writing to Morgan Stanley. The ASDP prohibits Mr. Moore from disclosing to Morgan Stanley any information concerning the Company that might influence the execution of the ASDP.

The ASDP was adopted in accordance with Viemed's insider trading policy and at a time when Mr. Moore was not aware of any material fact or material change relating to Viemed that had not been generally disclosed.

Up to 246,000 common shares may be sold under the ASDP pursuant to predetermined trading instructions over an approximately one-year term ending November 30, 2027. The shares subject to the ASDP represent less than 11% of the common shares beneficially owned directly and indirectly by Mr. Moore as disclosed in the Company's most recent proxy statement. Sales may commence as early as December 24, 2026, following the applicable waiting period under Rule 10b5-1. Sales under the ASDP are subject to a minimum floor price.

The arrangement has been authorized by the Company and contains meaningful restrictions on the ability of Mr. Moore and Moore Faster LLC to amend, suspend or terminate the ASDP. Any amendment, suspension or termination of the ASDP will be disclosed in accordance with applicable securities laws.

Dispositions by or on behalf of Mr. Moore under the ASDP will be reported in accordance with applicable securities laws. Information regarding the ASDP and transactions thereunder may be accessed on SEDI at www.sedi.ca and www.sec.gov.

This announcement is made pursuant to the recommended practices set forth in Staff Notice 55-317- Automatic Securities Disposition Plans of the Canadian Securities Administrators and will be available under the Company's SEDAR+ profile at www.sedarplus.ca.

ABOUT VIEMED HEALTHCARE, INC.

Viemed is a provider of home medical equipment and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. Viemed's model emphasizes efficient, high-quality care delivered in the home through a combination of high-touch clinical support and technology-enabled services, including therapy, education, and counseling provided by our clinical practitioners. For more information, visit our website at www.viemed.com.

For further information, please contact:

Investor Relations
[email protected]

Trae Fitzgerald
Chief Financial Officer
Viemed Healthcare, Inc.
(337) 504-3802

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or "forward-looking information" as such term is defined in applicable Canadian securities legislation (collectively, "forward-looking statements"). Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "potential", "scheduled", "estimates", "forecasts", "intends", "anticipates", "believes", "projects", or the negatives thereof or variations of such words and phrases or statements that certain actions, events or results "will", "should", "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative of these terms or comparable terminology. All statements other than statements of historical fact, including those that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance, including the expected operation, term, timing and number of dispositions under the ASDP and the restrictions on Mr. Moore's ability to amend, suspend or terminate the ASDP, are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties that could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking statements to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include, without limitation. those risk factors discussed or referred to in the Company's disclosure documents filed with the U.S. Securities and Exchange Commission (the "SEC") available on the SEC's website at www.sec.gov, including the Company's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and with the securities regulatory authorities in certain provinces of Canada available at www.sedarplus.ca. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking statements prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking statements are expressly qualified in their entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking statements. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking statements, other than as required by applicable law.

SOURCE: Viemed Healthcare, Inc.



View the original press release on ACCESS Newswire

S.Weaver--TFWP